| Line 1: |
Line 1: |
| − | '''Annual Goals:''' | + | '''AY '26-'27 Goals''' |
| − | *Get a manuscript ready for submission | + | *Submit a manuscript for publication |
| − | *RISE 1 application | + | **Meet w/ Nina |
| − | *Identify additional funding sources | + | *Submit RISE 1 application |
| | + | **Think deeply about research directions and goals |
| | + | **Literature review to refine research aims |
| | + | **Figure out organizational system to be more productive with research time |
| | + | **Start identifying mentors |
| | + | *Identify additional funding sources and apply |
| | *Start recruiting a research team | | *Start recruiting a research team |
| − |
| |
| − | '''Monthly Goals:'''
| |
| − | *Meet w/ Nina
| |
| − | *Think deeply about research directions and goals
| |
| − | *Literature review to refine research aims
| |
| − | *Figure out organizational system to be more productive with research time
| |
| − | *Start identifying mentors
| |
| | | | |
| | == 9/22 == | | == 9/22 == |
| Line 28: |
Line 26: |
| | **20 years ago he licensed some PK/PD software to GE but no one bought it. A Norwegian company tried the same thing, also without success. He is now trying to get it integrated into EPIC. Is it just a marketing problem that no one wants to buy it? They've shown that it changes how people deliver anesthesia (typically they use less, specifically opioid). | | **20 years ago he licensed some PK/PD software to GE but no one bought it. A Norwegian company tried the same thing, also without success. He is now trying to get it integrated into EPIC. Is it just a marketing problem that no one wants to buy it? They've shown that it changes how people deliver anesthesia (typically they use less, specifically opioid). |
| | **He thinks the big thing that is lacking from Christian's research is volunteer studies. | | **He thinks the big thing that is lacking from Christian's research is volunteer studies. |
| | + | **He did a bunch of PD studies looking at responses to different noxious stimuli at various effect site concentrations. Still has the equipment. |
| | | | |
| | *Read through the RISE application. | | *Read through the RISE application. |
| Line 39: |
Line 38: |
| | | | |
| | *Feasibile and high-impact research ideas: | | *Feasibile and high-impact research ideas: |
| − | **Depression | + | **[[Intra-op Treatment and Prophylaxis Against Depression | Depression]] |
| | ***What is the disease burden of depression in the general surgical population? [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c14%7c1&Counter5=SS_view_found_complete%7c40404498%7cmedall%7cmedline%7cmed29&Counter5Data=40404498%7cmedall%7cmedline%7cmed29 BJA article] that finds 20% burden of depression in the surgical patients during the pre-op period. They also note that patients have a 2.5x higher risk of non-home discharge. [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c16%7c1&Counter5=SS_view_found_complete%7c41495495%7cmedall%7cmedline%7cmed29&Counter5Data=41495495%7cmedall%7cmedline%7cmed29 2026 systematic review and meta-analysis] showing that about 1/4 of surgical cancer patients have depression. [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c19%7c1&Counter5=SS_view_found_complete%7c41337802%7cmedall%7cmedline%7cmed29&Counter5Data=41337802%7cmedall%7cmedline%7cmed29 2026 Journal of Clinical Neuroscience] article showed a 4-fold increase in risk of re-operation in ACDF patients who were depressed. | | ***What is the disease burden of depression in the general surgical population? [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c14%7c1&Counter5=SS_view_found_complete%7c40404498%7cmedall%7cmedline%7cmed29&Counter5Data=40404498%7cmedall%7cmedline%7cmed29 BJA article] that finds 20% burden of depression in the surgical patients during the pre-op period. They also note that patients have a 2.5x higher risk of non-home discharge. [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c16%7c1&Counter5=SS_view_found_complete%7c41495495%7cmedall%7cmedline%7cmed29&Counter5Data=41495495%7cmedall%7cmedline%7cmed29 2026 systematic review and meta-analysis] showing that about 1/4 of surgical cancer patients have depression. [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c19%7c1&Counter5=SS_view_found_complete%7c41337802%7cmedall%7cmedline%7cmed29&Counter5Data=41337802%7cmedall%7cmedline%7cmed29 2026 Journal of Clinical Neuroscience] article showed a 4-fold increase in risk of re-operation in ACDF patients who were depressed. |
| | ***What is the incidence of post-operative depression in general surgical patients without pre-existing depression? What if they have a family or personal history of depression? | | ***What is the incidence of post-operative depression in general surgical patients without pre-existing depression? What if they have a family or personal history of depression? |
| − | ***Do ketamine, TIVA w/ propofol, TIVA w/ remimazolam, psychedelics, or burst suppression modulate the post-operative risk? [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c2%7c1&Counter5=SS_view_found_complete%7c42657795%7cmedall%7cmedline%7cmedl&Counter5Data=42657795%7cmedall%7cmedline%7cmedl RCT happening in China right now] | + | ***Do ketamine, TIVA w/ propofol, TIVA w/ remimazolam, psychedelics, or burst suppression modulate the post-operative risk? [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c2%7c1&Counter5=SS_view_found_complete%7c42657795%7cmedall%7cmedline%7cmedl&Counter5Data=42657795%7cmedall%7cmedline%7cmedl RCT happening in China right now]. Another RCT done in China with 142 cardiac surgery patients showed [https://ovidsp.dc2.ovid.com/ovid-new-a/ovidweb.cgi?&S=20719da3-5171-468d-a340-25cdcf20c6e6%7cmain&Complete+Reference=S.sh.50%7c23%7c1&Counter5=SS_view_found_complete%7c41285329%7cmedall%7cmedline%7cmed28&Counter5Data=41285329%7cmedall%7cmedline%7cmed28 significantly decreased post-operative depression] in patients who got a single dose of ketamine (0.3 mg/kg) at induction. After reviewing the first 51 results on Ovid Medline, I saved selected abstracts to Box. |
| | **CLAN | | **CLAN |
| | ***When combined with SEEG electrodes or data from Parkinson's patients with deep-brain stimulators, can we resolve temporal and spatial activity of deep subcortical structures with ICA from frontal or full EEG? [https://pubmed.ncbi.nlm.nih.gov/28575667/ steerable non-invasive DBS] | | ***When combined with SEEG electrodes or data from Parkinson's patients with deep-brain stimulators, can we resolve temporal and spatial activity of deep subcortical structures with ICA from frontal or full EEG? [https://pubmed.ncbi.nlm.nih.gov/28575667/ steerable non-invasive DBS] |
| Line 59: |
Line 58: |
| | | | |
| | *Low-impact, very feasible research ideas: | | *Low-impact, very feasible research ideas: |
| − | **SCD-FR | + | **SCD-PV |
| | **Better late than never PONV | | **Better late than never PONV |